脳神経外科の世界市場 - 2025年～2033年

脳神経外科の世界市場は、2024年に49億4,000万米ドルに達し、2033年には75億4,000万米ドルに達すると予測され、予測期間2025年～2033年にはCAGR 4.5％で成長すると予測されています。

脳神経外科は、神経学的問題の診断、治療、リハビリテーションに関わる医学の専門分野です。脳、脊髄、末梢神経、脳血管系を含みます。脳神経外科医は、外傷、腫瘍、先天性異常、変性疾患などの障害を治療するために、幅広い外科的処置を行う訓練を受けています。この分野には、手術的処置と非手術的処置の両方が含まれるため、予防、診断、リハビリテーションを含む、患者ケアへのより包括的なアプローチが可能です。

脳神経外科は、活動的な専門分野として、技術的および外科的な飛躍的進歩に対応して常に変化しています。ロボット支援手術や術中画像診断のような技術革新は、手術の精度と患者の転帰を向上させる。さらに、神経疾患に対する理解が深まるにつれて、新しい治療法の研究が推進され、神経外科医がより複雑な神経疾患を管理できるようになるかもしれません。結局のところ、脳神経外科は、世界中の人々が経験する最も困難な健康問題のいくつかに対処するため、現代医療の重要な一部なのです。

市場力学：

促進要因と抑制要因

技術的進歩

技術の進歩は、世界の脳神経外科市場の成長において重要な要因となることが予想されます。脳神経外科の進化に伴い、外科手術の手順や機器の進歩により、さまざまな神経疾患に対する治療の精度や有効性が向上しています。人工知能（AI）や機械学習（ML）などの最新技術の統合により、診断や治療の手順が変革され、より正確な評価や患者に合わせた治療手順が可能になります。

例えば、中国科学院（CAS）傘下の香港の研究センターは2024年3月、医療業界がこの手術用の専門データベースの不足に直面している中でさえ、複雑な脳手術を支援するために新しい人工知能（AI）ツールCARES Copilot 1.0を発表しました。CARES Copilot 1.0は、脳神経外科医がより効率的な臨床診断を行い、十分な文献に基づいてより適切な医療判断を下せるよう支援するAIモデルです。

低侵襲手術は、脳神経外科におけるさらなる重要な成果です。一般的な開腹手術よりも小さな切開創を用いるこれらのアプローチは、患者の外傷を少なくし、回復を早め、合併症を少なくします。神経内視鏡やロボット支援手術システムなどの特殊機器の導入により、困難な手術がより正確かつ効率的に行われるようになった。その結果、患者は回復時間の短縮と治療成績の向上という恩恵を受けることができ、こうした画期的な外科的アプローチに対する需要が高まっています。

さらに、脳神経外科市場では、手術能力を向上させる次世代機器の開発に焦点を当てた研究開発が活発化しています。メーカー各社は、リアルタイムの画像処理とAI機能を組み込んだ新しい電動ツールの開発に積極的に投資しており、外科医は手術中に比類ないレベルの精度を得ることができます。このような技術革新の重視は、業務効率を高めるだけでなく、患者の個別の医療プロファイルに基づいて個々のニーズに合わせた治療法を提供するオーダーメイド医療への傾向の高まりにも対応しています。

例えば、インサイテックは2024年4月、次世代脳神経外科用プラットフォームを欧州で発売すると発表しました。また、Exablate PrimeもCE認可を取得しました。この画期的な装置は、磁気共鳴画像（MRI）ガイド下集束超音波技術を用いた既存のExablate Neuroプラットフォームを大幅に強化するものです。本態性振戦やパーキンソン病などの薬物治療抵抗性の運動障害を治療するために設計されたExablate Primeは、外来手術として切開なしの脳神経外科を可能にし、患者に回復時間や入院期間を最小限に抑える非侵襲的治療の選択肢を提供します。

脳神経外科装置の高額な費用

脳神経外科機器の高コストなどの要因が、脳神経外科の世界市場を阻害すると予想されています。神経外科用機器の高コストは、世界の脳神経外科産業の成長を著しく阻害すると予想されます。手術技術の向上に対するニーズが高まるにつれ、複雑な機器のコストも上昇します。先端技術の購入と維持にかかるコストは、特に経済的に余裕のない地域では、多くのヘルスケア施設にとって大きな課題となり得る。このシナリオは、これらの新しい機器を効率的に利用するために、スタッフに指導するための継続的な投資の必要性によってさらに複雑になり、病院の予算に新たなコストの層が加わることになります。

例えば、国立衛生研究所によると、脳深部刺激装置の費用は10,000ドルから14,000ドルです。脳深部刺激療法にかかる手術費用と装置費用の合計（患者1人当たり）は、27,497ドルから35,531ドルです。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 技術的進歩
  • 抑制要因
  • 脳神経外科機器の高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIの見解

第6章 製品別

• 神経介入デバイス
• 脳神経外科ソフトウェア
• 神経内視鏡
• 放射線手術システム
• 脳神経外科用アブレーション装置
• その他

第7章 用途別

• 脳腫瘍
• 脳血管外科
• 皮質マッピング
• パーキンソン病と振戦
• その他

第8章 年齢層別

• 小児
• 成人
• 高齢者

第9章 エンドユーザー別

• 病院
• 脳神経外科センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• Medtronic
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Abbott
• Boston Scientific Corporation
• Elekta
• Brainlab AG
• B. Braun SE
• MicroVention, Inc.
• Aleva Neurotherapeutics
• Integra LifeSciences
• Stryker

第13章 付録

The global neurosurgery market reached US$ 4.94 billion in 2024 and is expected to reach US$ 7.54 billion by 2033, growing at a CAGR of 4.5% during the forecast period 2025-2033.

Neurosurgery is a specialized field of medicine concerned with the diagnosis, treatment, and rehabilitation of neurological concerns. This encompasses the brain, spinal cord, peripheral nerves, and cerebrovascular system. Neurosurgeons are trained to undertake a wide range of surgical procedures to treat disorders such as traumatic injuries, tumors, congenital abnormalities, and degenerative diseases. The field comprises both operative and non-operative management procedures, allowing for a more comprehensive approach to patient care, including prevention, diagnosis, and rehabilitation.

Neurosurgery, as an active specialization, constantly changes in response to technological and surgical breakthroughs. Innovations like robotic-assisted surgery and intraoperative imaging improve procedure precision and patient outcomes. Furthermore, a better understanding of neurological diseases is driving research into new treatment methods, which may allow neurosurgeons to manage more complex neurological conditions. Ultimately, neurosurgery is an important part of modern medicine since it addresses some of the most difficult health concerns that people experience around the world.

Market Dynamics: Drivers & Restraints

Technological advancements

The Technological Advancements are expected to be a significant factor in the growth of the global neurosurgery market. As neurosurgery evolves, advances in surgical procedures and equipment improve the precision and efficacy of treatments for a variety of neurological diseases. The integration of modern technology such as artificial intelligence (AI) and machine learning (ML) is transforming diagnostic and therapeutic procedures, allowing for more accurate assessments and personalized treatment procedures for patients.

For instance, in March 2024, A Hong Kong-based research center under the Chinese Academy of Sciences (CAS) launched a new artificial intelligence (AI) tool CARES Copilot 1.0 to assist in complex brain surgery, even as the healthcare industry deals with an inadequate number of specialized databases for this procedure. CARES Copilot 1.0 AI model to help neurosurgeons provide more efficient clinical diagnoses and make better medical judgments based on sufficient references.

Minimally invasive surgical procedures are an additional significant accomplishment in neurosurgery. These approaches, which use smaller incisions than typical open surgeries, result in less patient trauma, faster recovery, and fewer complications. The introduction of specialized devices, such as neuroendoscopic tools and robotic-assisted surgical systems, has enabled difficult procedures to be performed more accurately and efficiently. As a result, patients benefit from faster recovery times and better outcomes, increasing demand for these revolutionary surgical approaches.

Furthermore, the neurosurgery market is experiencing a rise in R&D focused on developing next-generation equipment that improves surgical capabilities. Manufacturers are progressively investing in the development of new power tools that incorporate real-time imaging and AI capabilities, giving surgeons unparalleled levels of precision during procedures. This emphasis on technology innovation not only enhances operational efficiency but also corresponds with the growing trend toward customized medicine, in which therapies are tailored to the individual needs of patients based on their distinct medical profiles.

For instance, in April 2024, Insightec announced the launch of its next-generation neurosurgical platform in Europe. Exablate Prime also received CE clearance. This revolutionary device substantially enhances the existing Exablate Neuro platform, which uses magnetic resonance imaging (MRI)-guided focused ultrasound technology. Exablate Prime, designed to treat medication-refractory movement disorders such as essential tremor and Parkinson's disease, allows for incision-less neurosurgery as an outpatient operation, allowing patients a non-invasive treatment alternative that minimizes recovery time and hospital stays.

High costs of neurosurgery equipment

Factors such as high costs of neurosurgery equipment are expected to hamper the global neurosurgery market. The high costs of neurosurgical devices are expected to severely impede the growth of the global neurosurgery industry. As the need for improved surgical technology grows, so does the cost of the complex equipment. The cost of buying and maintaining advanced technology can be a significant challenge for many healthcare facilities, especially in areas with limited economies. This scenario is further complicated by the ongoing need to invest in instructing staff to utilize these new instruments efficiently, which adds another layer of cost to hospitals' budgets.

For instance, according to the National Institute of Health, the cost of a deep brain stimulation device ranges from $10,000 to $14,000. The total operative and device costs (per patient) range from $27,497 to $35,531 for deep brain stimulation.

Segment Analysis

The global neurosurgery market is segmented based on product, application, age group, end-user, and region.

Neuro interventional devices segment is expected to dominate the global neurosurgery market share

The radiofrequency coils segment is anticipated to dominate the global neurosurgery market owing to its technological advancements, recent launches and approvals, and increase in the number of neurological disorders. One of the primary benefits of neuro-interventional devices is their capacity to facilitate minimally invasive operations, which are associated with shorter recovery times, fewer postoperative problems, and less trauma for patients when compared to traditional open surgeries. These devices comprise several instruments including stents, embolic coils, and neurothrombectomy devices, all of which are intended to treat problems such as aneurysms and ischemic strokes using endovascular techniques. As healthcare practitioners become more aware of the benefits of these procedures, the demand for neuro-interventional devices is projected to increase significantly.

Furthermore, technological improvements have resulted in the creation of increasingly complex neuro-interventional devices that improve procedural accuracy and safety. Neurosurgeons may now execute difficult operations with better precision because of developments in robotics and imaging technology. This technical advancement not only improves surgical outcomes but also broadens the types of conditions that can be treated with these devices. As a result, healthcare institutions are more likely to invest in neuro-interventional technology, strengthening their position as an important segment of the neurosurgery market.

For instance, in February 2024, Royal Philips launched the new Azurion neuro biplane interventional system, which significantly improves its image-guided therapeutic system. The technology is intended to streamline neurovascular operations, allowing care teams to make faster judgments, treat more patients, and achieve better results. It has superior 2D and 3D imaging capabilities, as well as adjustable X-ray detector positioning. The device allows neuro-interventionists to carry out procedures more efficiently, perhaps increasing patient outcomes. This improves the experience for both staff and patients while also helping to reduce the cost of care. The Azurion neuro biplane system incorporates Philips' ClarityIQ low-dose imaging technology, neuro-specific tools, and services, resulting in a fully integrated solution for smooth procedural workflows, precise diagnosis, and treatment.

Moreover, in June 2024, MicroVention, a subsidiary of Terumo Corporation, launched its LVIS EVO Intraluminal Support Device in the United States. It is specifically intended for the treatment of wide-neck intracranial aneurysms. This novel device is now commercially accessible and represents a substantial improvement in neurovascular therapies.

Geographical Analysis

North America is expected to hold a significant position in the global neurosurgery market share

North America will likely account for a significant share of the global neurosurgery market, owing to its advanced healthcare infrastructure, a high prevalence of neurological disorders, technological advancements, and recent launches and approvals. One of the key drivers of the North America neurosurgery market is a strong healthcare system that allows for better surgical methods and technology. The United States, in particular, has established itself as a leader in medical technology development, with a number of major companies functioning in the neurosurgical field. These corporations constantly invest in R&D to develop new devices and improve existing ones. The existence of large manufacturers, as well as a robust regulatory environment, make it easier to introduce advanced neurosurgical devices, which enhances patient care.

For instance, in March 2024, Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced that it had launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. This launch expands upon the company's prior ENROUTE Transcarotid Stent System, offering additional configurations to better tailor the Transcarotid Artery Revascularization (TCAR) procedure to patient anatomy.

Moreover, in April 2024, Expanse ICE announced that the ICE Aspiration System had received 510(k) clearance from the U.S. Food and Drug Administration. The ICE System is specifically designed to address the complex challenges associated with peripheral thrombectomies. Blood clots are the third most common vascular disease.

Asia Pacific is growing at the fastest pace in the global neurosurgery market

The Asia Pacific region is emerging as the fastest-growing market for neurosurgery, owing to a combination of demographic trends, increased healthcare investment, recent launches, and a rising number of neurological disorders. One of the most significant technical advances in the APAC neurosurgery market is the incorporation of robotics and minimally invasive techniques. These innovations enable more accurate surgical procedures, lowering the trauma associated with traditional open surgeries. Additionally, high-definition imaging tools have transformed preoperative planning and intraoperative guidance in neurosurgery. Advanced imaging modalities, such as MRI and CT scans, provide extensive information about brain anatomy, allowing surgeons to see complicated structures before and during surgery. This ability improves surgical precision, lowers the risk of complications, and, eventually, leads to improved patient results. Furthermore, the introduction of artificial intelligence (AI) and machine learning into diagnostic and surgical technologies improves the efficiency and effectiveness of neurosurgical treatments.

For instance, in February 2024, Indian medical imaging AI company InMed AI launched a new AI-powered tool for screening traumatic brain injuries (TBI). The Neuroshield CT TBI is a decision support tool for detecting and quantifying intracranial hemorrhage, fracture, and midline shift. Utilizing AI, it automatically processes brain CT images and alerts clinicians of critical findings.

Competitive Landscape

The major global players in the global neurosurgery market include Medtronic, Abbott, Boston Scientific Corporation, Elekta, Brainlab AG, B. Braun SE, MicroVention, Inc., Aleva Neurotherapeutics, Integra LifeSciences, and Stryker among others.

Emerging Players

Neurotech Innovations, Cadence Neuroscience, and Synaptive Medical among others

Key Developments

• In September 2024, ZEISS Medical Technology launched the KINEVO 900 S. The latest Robotic Visualization System is a further development of the successful ZEISS KINEVO 900 platform. With the best digital visualization, collaborative assistant functions, and connected intelligence, ZEISS KINEVO 900 S offers more clarity for complex surgical procedures in neurosurgery and other surgical disciplines.
• In November 2023, Amrita Hospital, Kochi opened Kerala's first neuro endoscopy center, the Amrita Centre for Neuro Endoscopy (ACNE). The center has an expert team in skull base, cranial, spine, robotic, and pediatric endoscopy, providing specialized care in endoscopic neurosurgery.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global neurosurgery market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product
• 3.2. Snippet by Application
• 3.3. Snippet by Age Group
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
  • 4.1.2. Technological Advancements
  • 4.1.3. Restraints
  • 4.1.4. High Costs of Neurosurgery Equipment
  • 4.1.5. Opportunity
  • 4.1.6. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Product

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 6.1.2. Market Attractiveness Index, By Product
• 6.2. Neuro Interventional Devices*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Neurosurgery Software
• 6.4. Neuroendoscopes
• 6.5. Radiosurgery Systems
• 6.6. Neurosurgical Ablation Devices
• 6.7. Others

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Brain Tumors*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Cerebrovascular Surgery
• 7.4. Cortical Mapping
• 7.5. Parkinson's Disease and Tremors
• 7.6. Others

8. By Age Group

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age group
  • 8.1.2. Market Attractiveness Index, By Age group
• 8.2. Pediatric
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Adult
• 8.4. Geriatric

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Neurosurgery Centers
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Medtronic*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Abbott
• 12.3. Boston Scientific Corporation
• 12.4. Elekta
• 12.5. Brainlab AG
• 12.6. B. Braun SE
• 12.7. MicroVention, Inc.
• 12.8. Aleva Neurotherapeutics
• 12.9. Integra LifeSciences
• 12.10. Stryker

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us